Trump’s Bold Picks Shake Up Life Sciences

The Trump administration’s new appointees, including Elon Musk, Dr. Marty Makary, Dr. Jay Bhattacharya, and Robert F. Kennedy Jr., promise a significant shift for the life sciences industry. Each brings a disruptive approach to their respective agencies, signaling potential changes in clinical research, drug advertising, and regulatory oversight.Key highlights:Elon Musk will lead the Department of Government Efficiency, introducing innovation-focused reforms that could streamline processes bu...